|
|
|
|
ActimmunePR Newswire (press release), The pulmonology portfolio includes Actimmune(R) (interferon gamma-1b), pirfenidone and research programs. Actimmune(R) is being ... InterMune Completes Divestiture of Infergen(R) for up to $135.5 ... Jan 3, 2006 PR Newswire (press release), ...step in refocusing our corporate strategy to direct resources to our three key development programs -- our Phase III study evaluating Actimmune(R) for ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |